Weill Cornell Medicine

Weill Cornell Medicine is the biomedical research unit and medical school of Cornell University, a private Ivy League university

Reversing osteoporosis . . . in mice

A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis and fractures, according to new research by Weill Cornell Medicine scientists. The findings, published May 21 in Nature Medicine, show that a substance, which is best known for spurring nerve

Reversing osteoporosis . . . in mice

A nanotechnology-enhanced biochip could detect cancers, malaria and viral diseases in their progression with a pin prick blood test

The difficulty in spotting minute amounts of disease circulating in the bloodstream has proven a stumbling block in the detection and treatment of cancers that advance stealthily with few symptoms. With a novel electrochemical biosensing device that identifies the tiniest signals these biomarkers emit, a pair of NJIT inventors are hoping to bridge this gap.

A nanotechnology-enhanced biochip could detect cancers, malaria and viral diseases in their progression with a pin prick blood test

Artificial intelligence weighs in on whether an in vitro fertilized human embryo has a high potential to progress to a successful pregnancy

A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy. The technique, which analyzes time-lapse images of the early-stage embryos, could improve the success rate of in vitro fertilization

Artificial intelligence weighs in on whether an in vitro fertilized human embryo has a high potential to progress to a successful pregnancy

Toxin-Emitting Bacteria Being Evaluated as a Potential Multiple Sclerosis Trigger

VARIANT OF COMMON SOIL-BASED PATHOGEN FOUND FOR THE FIRST TIME IN A PATIENT WITH MS RESEARCHERS FIND EVIDENCE OF SIMILAR INFECTION IN OTHER MS PATIENTS A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis (MS), a chronic, debilitating disorder that damages myelin

Toxin-Emitting Bacteria Being Evaluated as a Potential Multiple Sclerosis Trigger

The Latest Bing News on:

Weill Cornell Medicine Research

Imbalance in gum bacteria linked to Alzheimer's disease biomarker
on April 12, 2021 at 7:10 am
Older adults with more harmful than healthy bacteria in their gums are more likely to have evidence for amyloid beta—a key biomarker for Alzheimer's disease—in their cerebrospinal fluid (CSF), ...
Imbalanced bacterial community in the gums linked to Alzheimer's disease biomarker
on April 12, 2021 at 5:21 am
Leon is also the director of the Brain Health Imaging Institute at Weill Cornell Medicine. The researchers studied 48 healthy, cognitively normal adults ages 65 and older. Participants underwent oral ...
Startup collaborates with NewYork-Presbyterian, Vanderbilt to test video game therapy for COVID 'brain fog'
on April 7, 2021 at 1:19 pm
Boston-based Akili Interactive is collaborating with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate the company's digital therapeutic, which ...
PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL ...
on April 7, 2021 at 6:15 am
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, develo ...
Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AK
on April 7, 2021 at 2:00 am
we are concerned about how these cognitive difficulties may affect people in their daily lives,” said Gunning Ph.D., Vice Chair of Research in the Department of Psychiatry, associate professor of ...

The Latest Google Headlines on:

Weill Cornell Medicine Research

The Latest Bing News on:

Weill Cornell Medicine Discovery

Stem Cell Research Unlocks a New Discovery about Controlling Genes
on April 9, 2021 at 8:57 am
The DNA in our genes contains the instructions needed to manufacture all of the proteins in our cells. These proteins, in turn, do the work that keeps our bodies functioning. Therefore, knowing how ...
Repare Therapeutics to Highlight Program Progress for RP-6306 at Today’s Virtual Investor Day Event
on April 8, 2021 at 12:04 pm
Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center 11:05 a.m. – 11:35 a.m. ET Target Discovery & Biology of RP-6306 & STEP Characterization Table Michael Zinda, Ph.D., Executive ...
Volastra Therapeutics Extends Seed Financing to $44 Million to Advance Drug Discovery Programs to Prevent Cancer Metastasis
on April 6, 2021 at 4:00 am
Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of metastatic cancer, today announced the extension of its original $12 million seed round to ...
NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications
on March 31, 2021 at 3:00 am
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational ... Dr. Christopher Mason at Weill Cornell Medicine, was entitled "Shotgun ...
Repare Therapeutics to Introduce RP-6306, a Potent and Specific Inhibitor of a Novel Target, at Virtual Investor Day on April 8
on March 30, 2021 at 1:05 pm
Repare Therapeutics’ executive management team will be joined by two distinguished physicians: Carol Aghajanian, MD, Chief, Gynecologic Medical Oncology Service, Professor of Medicine, Weill Cornell ...